High‐frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l‐3,4‐dihydroxyphenylalanine in dopaminergic denervated rats

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Neuroscience

• Publication date

  2007-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1460-9568.2007.05747.xPMID 17822436PMCID PMC2798123
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deep brain stimulation in a rat model modulates TH, CaMKIIa and Homer1 gene expression

  2007cited by this paper
• Subthalamic Stimulation-Induced Forelimb Dyskinesias Are Linked to an Increase in Glutamate Levels in the Substantia Nigra Pars Reticulata

  2006cited by this paper
• S4 Stimulation Of The Subthalamic Nucleus In Parkinson's Disease

  2006cited by this paper
• Stimulation of the Subthalamic Nucleus in Parkinson's Disease Does Not Produce Striatal Dopamine Release.

  2005cited by this paper
• Pallidal Origin of GABA Release within the Substantia Nigra Pars Reticulata during High-Frequency Stimulation of the Subthalamic Nucleus

  2005cited by this paper
• Preoperative Clinical Predictors of Response to Bilateral Subthalamic Stimulation in Patients with Parkinson’s Disease

  2005cited by this paper
• Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.

  2005cited by this paper
• Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both.

  2004cited by this paper
• Levodopa and the progression of Parkinson's disease.

  2004cited by this paper
• Neurochemical Mechanisms Induced by High Frequency Stimulation of the Subthalamic Nucleus: Increase of Extracellular Striatal Glutamate and GABA in Normal and Hemiparkinsonian Rats

  2003cited by this paper
• Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease

  2003cited by this paper
• High‐frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats

  2003cited by this paper
• Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease.

  2003cited by this paper
• Effects of high-frequency stimulation in the internal globus pallidus on the activity of thalamic neurons in the awake monkey.

  2003cited by this paper
• Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex.

  2003cited by this paper
• Spontaneous and Evoked Activity of Substantia Nigra Pars Reticulata Neurons during High-Frequency Stimulation of the Subthalamic Nucleus

  2003cited by this paper
• Stimulation of the Subthalamic Nucleus in Parkinson’s Disease Does Not Produce Striatal Dopamine Release

  2003cited by this paper
• Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

  2003cited by this paper
• Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans

  2003cited by this paper
• Influence of the frequency parameter on extracellular glutamate and γ‐aminobutyric acid in substantia nigra and globus pallidus during electrical stimulation of subthalamic nucleus in rats

  2003cited by this paper
• The impact of stereotactic pallidal surgery on the dopamine D2 receptor in Parkinson disease: a positron emission tomography study.

  2003cited by this paper
• Mechanisms of deep brain stimulation

  2002cited by this paper
• Clinical predictive factors of subthalamic stimulation in Parkinson's disease.

  2002cited by this paper
• High-Frequency Stimulation of the Subthalamic Nucleus Selectively Reverses Dopamine Denervation-Induced Cellular Defects in the Output Structures of the Basal Ganglia in the Rat

  2002cited by this paper
• Mechanisms of deep brain stimulation

  2002cited by this paper
• Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats.

  2002cited by this paper
• Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats.

  2001cited by this paper
• Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover

  2001cited by this paper
• Research report Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra

  2001cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Deep brain stimulation of the subthalamic nucleus: Clinical effectiveness and safety

  2001cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.

  2001cited by this paper
• High Frequency Stimulation of the Subthalamic Nucleus Increases the Extracellular Contents of Striatal Dopamine in Normal and Partially Dopaminergic Denervated Rats

  2001cited by this paper
• Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation

  2000cited by this paper
• High frequency stimulation of the subthalamic nucleus infuences striatal dopaminergic metabolism in the naive rat

  2000cited by this paper
• Pathophysiologic basis of surgery for Parkinson's disease.

  2000cited by this paper
• Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson’s disease

  2000cited by this paper
• Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease.

  2000cited by this paper
• Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat

  2000cited by this paper
• Preventing levodopa-induced dyskinesias.

  2000cited by this paper
• Continuous dopamine-receptor stimulation in early Parkinson's disease.

  2000cited by this paper
• ELECTRICAL STIMULATION OF THE SUBTHALAMIC NUCLEUS IN ADVANCED PARKINSON’S DISEASE ELECTRICAL STIMULATION OF THE SUBTHALAMIC NUCLEUS IN ADVANCED PARKINSON’S DISEASE

  2000cited by this paper
• Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease

  1999cited by this paper
• Dopamine autoreceptor function is lost in advanced Parkinson’s disease

  1999cited by this paper
• Loss of long-duration response to levodopa over time in PD

  1999cited by this paper
• Surgical treatment of Parkinson's disease.

  1999cited by this paper
• Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease.

  1999cited by this paper
• Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum.

  1999cited by this paper
• Role of High‐Affinity Dopamine Uptake and Impulse Activity in the Appearance of Extracellular Dopamine in Striatum After Administration of Exogenous L‐DOPA

  1999cited by this paper
• Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.

  1998cited by this paper
• Long‐duration response to levodopa influences the pharmacodynamics of short‐duration response in Parkinson's disease

  1997cited by this paper
• Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease

  1997cited by this paper
• Immunochemical analysis of dopamine transporter protein in Parkinson's disease

  1997cited by this paper
• Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease.

  1997cited by this paper
• DA Uptake Sites, D1, and D2 Receptors, D2 and Preproenkephalin mRNAs and Fos Immunoreactivity in Rat Striatal Subregions after Partial Dopaminergic Degeneration

  1996cited by this paper
• The response to levodopa in parkinson's disease: Imposing pharmacological law and order

  1996cited by this paper
• Long‐Term Induction of Tyrosine Hydroxylase Expression: Compensatory Response to Partial Degeneration of the Dopaminergic Nigrostriatal System in the Rat Brain

  1995cited by this paper
• Long-duration response to levodopa

  1995cited by this paper
• Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data.

  1995cited by this paper
• PET studies on brain monoamine transporters with carbon-11-beta-CIT in Parkinson's disease.

  1995cited by this paper
• Neurotransmitter transporters: three important gene families for neuronal function.

  1994cited by this paper
• Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study

  1994cited by this paper
• The cortico-nigral projection in the rat: an anterograde tracing study with biotinylated dextran amine.

  1994cited by this paper
• Oral pulse levodopa therapy in mild Parkinson's disease

  1993cited by this paper
• Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenon.

  1992cited by this paper
• Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior.

  1991cited by this paper
• Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.

  1990cited by this paper
• Brain microdialysis studies on the control of dopamine release and metabolism in vivo.

  1990cited by this paper
• Compensations after lesions of central dopaminergic neurons: some clinical and basic implications.

  1990cited by this paper
• Response to a standard oral levodopa test in parkinsonian patients with and without motor fluctuations.

  1990cited by this paper
• The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons.

  1990cited by this paper
• In Vivo Mechanisms Underlying Dopamine Release from Rat Nigrostriatal Terminals: II. Studies Using Potassium and Tyramine

  1990cited by this paper
• Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease

  1990cited by this paper
• Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.

  1990cited by this paper
• In Vivo Mechanisms Underlying Dopamine Release from Rat Nigrostriatal Terminals: I. Studies Using Veratrine and Ouabain

  1990cited by this paper
• Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism.

  1989cited by this paper
• Continuous and intermittent levodopa differentially affect basal ganglia function

  1989cited by this paper
• Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.

  1988cited by this paper
• Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study

  1988cited by this paper
• Simultaneous determination of the rates of synthesis and metabolism of dopamine in various areas of the rat brain: application to the effects of (+)-amphetamine.

  1987cited by this paper
• Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage

  1987cited by this paper
• Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity.

  1987cited by this paper
• Detection of dopamine overflow and diffusion with voltammetry in slices of rat brain.

  1987cited by this paper
• Stimulation of the subthalamic nucleus enhances the release of dopamine in the rat substantia nigra.

  1986cited by this paper
• In vivo comparison of the regulation of releasable dopamine in the caudate nucleus and the nucleus accumbens of the rat brain

  1986cited by this paper
• Microdialysis in the study of extracellular levels of amino acids in the rat brain.

  1986cited by this paper
• Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs.

  1985cited by this paper
• Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism.

  1984cited by this paper
• CNS Dopamine Autoreceptors: Distribution, Pharmacology, and Function a

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Basal ganglia disease.

  1982cited by this paper
• AChE-stained horizontal sections of the rat brain in stereotaxic coordinates.

  1980cited by this paper
• Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.

  1980cited by this paper
• Tyrosine hydroxylase immunohistochemistry in human brain.

  1979cited by this paper
• Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors.

  1979cited by this paper
• Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors.

  1979cited by this paper
• The use of avidin-biotin interaction in immunoenzymatic techniques.

  1979cited by this paper
• Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.

  1977cited by this paper
• "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy.

  1976cited by this paper

• Deep Brain Stimulation Mechanisms in Parkinson's Disease: Immediate and Long-Term Effects.

  2024cites this paper
• Deep brain stimulation-induced neuroprotection: A critical appraisal.

  2022cites this paper
• Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking

  2021cites this paper
• Effects of subthalamic deep brain stimulation on striatal metabolic connectivity in a rat hemiparkinsonian model

  2019cites this paper
• The acute effects of dopaminergic medication and deep brain stimulation of subthalamic nucleus on basic executive functions including shifting, updating and inhibition in Parkinson’s disease patients

  2018cites this paper
• Learning to focus and focusing to learn : more than a cortical trick

  2018influential citation
• The pathophysiological mechanisms of motivational deficits in Parkinson's disease

  2018cites this paper
• Striatal Glutamate and GABA after High Frequency Subthalamic Stimulation in Parkinsonian Rat

  2017cites this paper
• Subthalamic nucleus deep brain stimulation on motor‐symptoms of Parkinson's disease: Focus on neurochemistry

  2017cites this paper
• Motivational Deficits in Parkinson’s Disease: Role of the Dopaminergic System and Deep-Brain Stimulation of the Subthalamic Nucleus

  2016cites this paper
• Mechanismen van diepe hersenstimulatie

  2016cites this paper
• The mechanisms of action of deep brain stimulation and ideas for the future development.

  2015cites this paper
• Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson’s disease

  2015cites this paper
• Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson’s Disease

  2015cites this paper
• Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats

  2015cites this paper
• Are δ-Opioid Receptors Involved in Deep Brain Stimulation?

  2015cites this paper
• Urinary profile of catecholamines and metabolites in Parkinson patients with deep brain stimulation

  2014cites this paper
• How does deep brain stimulation work

  2014cites this paper
• Neurotransmitter levels in basal ganglia during levodopa and deep brain stimulation treatment in Parkinson's disease

  2014cites this paper
• Modeling dyskinesia in animal models of Parkinson disease.

  2014cites this paper
• Subthalamotomy-induced changes in dopamine receptors in parkinsonian monkeys.

  2014cites this paper
• The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation.

  2014cites this paper
• Études de la subthalamotomie comme traitement des dyskinésies chez le primate parkinsonien

  2013cites this paper
• Striatal Molecular Signature of Subchronic Subthalamic Nucleus High Frequency Stimulation in Parkinsonian Rat

  2013cites this paper
• Evaluation of Metabolic State in Striatal Rat Model of Parkinson's Disease: before and after Deep Brain Stimulation

  2013cites this paper
• Intraoperative dopamine release during globus pallidus internus stimulation in Parkinson's disease

  2013cites this paper
• Deep Brain Stimulation of the Subthalamic and Entopeduncular Nuclei in an Animal Model of Tardive Dyskinesia

  2013cites this paper
• Deep brain stimulation: how does it work?

  2013cites this paper
• Raclopride or high‐frequency stimulation of the subthalamic nucleus stops cocaine‐induced motor stereotypy and restores related alterations in prefrontal basal ganglia circuits

  2012cites this paper
• A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission.

  2012cites this paper
• The Role of the Subthalamic Nucleus in L-DOPA Induced Dyskinesia in 6-Hydroxydopamine Lesioned Rats

  2012cites this paper
• Contribution of Serotonergic Transmission to the Motor and Cognitive Effects of High-Frequency Stimulation of the Subthalamic Nucleus or Levodopa in Parkinson’s Disease

  2012cites this paper
• Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease.

  2012cites this paper
• Mechanisms of High Frequency Stimulation of the Subthalamic Nucleus in Parkinson's Disease: From Local to Distal Effects on the Basal Ganglia Network

  2011cites this paper
• Biodegradable microspheres loaded with an anti-Parkinson prodrug: an in vivo pharmacokinetic study.

  2011cites this paper
• Diagnosis and Treatment of Parkinson's Disease

  2011cites this paper
• Monitoring Dopamine in the Mesocorticolimbic and Nigrostriatal Systems by Microdialysis: Relevance for Mood Disorders and Parkinson's Disease

  2011cites this paper
• Axonal failure during high frequency stimulation of rat subthalamic nucleus

  2011cites this paper
• High-Frequency Stimulation of the Subthalamic Nucleus and l-3,4-Dihydroxyphenylalanine Inhibit In Vivo Serotonin Release in the Prefrontal Cortex and Hippocampus in a Rat Model of Parkinson's Disease

  2010cites this paper
• Deep brain stimulation state of the art and novel stimulation targets.

  2010cites this paper
• In vivo microdialysis in Parkinson's research.

  2009cites this paper
• Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies.

  2009cites this paper
• Neuronal activity in the subthalamic nucleus modulates the release of dopamine in the monkey striatum

  2009cites this paper
• Induction de signaux calciques dans les cellules gliales de la substance noire réticulée par la stimulation électrique du noyau sous-thalamique

  2009cites this paper
• Deep brain stimulation in neurological diseases and experimental models: from molecule to complex behavior.

  2009cites this paper
• Long term high frequency stimulation of STN increases dopamine in the corpus striatum of hemiparkinsonian rhesus monkey.

  2009cites this paper
• Molecular, Cellular and Electrophysiological Changes Triggered by High-Frequency Stimulation of the Subthalamic Nucleus in Animal Models of Parkinson’s Disease

  2009cites this paper
• Deep brain stimulation: how does it work?

  2008cites this paper
• Hypersexuality following subthalamic nucleus stimulation for Parkinson's disease.

  2008cites this paper
• Mechanisms and targets of deep brain stimulation in movement disorders

  2008cites this paper
• Mechanisms of Deep Brain Stimulation

  2008cites this paper
• Deep Brain Stimulation

  2008cites this paper
• Latest view on the mechanism of action of deep brain stimulation

  2008influential citation